University of Natural Resources and Life Sciences, Vienna (BOKU) - Research portal

Logo BOKU Resarch Portal

Selected Publication:

Natale, V; Stadlmayr, G; Benedetti, F; Stadlbauer, K; Ruker, F; Wozniak-Knopp, G.
(2022): Trispecific antibodies produced from mAb(2) pairs by controlled Fab-arm exchange
BIOL CHEM. 2022; 403(5-6): 509-523. FullText FullText_BOKU

Bispecific antibodies and antibody fragments are therapeutics of growing importance. They are clinically applied for effector cell engagement, enhanced targeting selectivity, addressing of multiple cellular pathways and active transfer of certain activities into difficult-to-reach compartments. These functionalities could profit from a third antigen specificity. In this work we have employed symmetrical bispecific parental antibodies of mAb(2) format, which feature a novel antigen binding site in the C(H)3 domains, and engineered them with a minimal number of point mutations to guide the formation of a controlled Fab-arm exchanged trispecific antibody at a high yield after reduction and re-oxidation. Two model antibodies, one reactive with EGFR, Her2 and VEGF, and one with Fab-arms binding to Ang2 and VEGF and an Fc fragment binding to VEGF, were prepared and examined for heterodimeric status, stability, antigen binding properties and biological activity. Resulting molecules were of good biophysical characteristics and retained antigen reactivity and biological activity of the parental mAb(2) constructs.
Authors BOKU Wien:
Benedetti Filippo
Natale Veronica
R√ľker Florian
Stadlbauer Katharina
Stadlmayr Gerhard
Wozniak-Knopp Gordana

Find related publications in this database (Keywords)
antigen-binding Fc fragment
multispecific antibodies
VEGF inhibition

© BOKU Wien Imprint